JPMorgan Chase Financial (AMJB) issues uncapped accelerated barrier notes tied to major indices
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is issuing $2,132,000 of Uncapped Accelerated Barrier Notes linked to the least performing of the Dow Jones Industrial Average®, the Nasdaq-100 Index® and the Russell 2000® Index, maturing on November 10, 2028.
The notes offer 2.0x leveraged upside on any positive performance of the worst-performing index at maturity, with no cap on gains. A 70% barrier applies to each index: if all final index levels are at or above 70% of their initial values, principal is repaid in full; if any index finishes below its barrier, repayment is reduced one-for-one with the decline of the least performing index, and investors can lose some or all principal.
The notes pay no interest or dividends, are unsecured and unsubordinated obligations subject to the credit risk of both JPMorgan Financial and JPMorgan Chase & Co., and will not be listed on any exchange. The price to public is $1,000 per note, including $9.50 in selling commissions, with net proceeds to the issuer of $990.50 per note. The initial estimated value is $974.80 per $1,000 note, reflecting embedded costs for selling, structuring and hedging.
Positive
- None.
Negative
- None.
FAQ
What is JPMorgan Chase Financial (AMJB) offering in this 424B2 filing?
The company is issuing Uncapped Accelerated Barrier Notes due November 10, 2028, linked to the least performing of the Dow Jones Industrial Average®, the Nasdaq-100 Index® and the Russell 2000® Index, with a total offering size of $2,132,000.
How do the uncapped accelerated barrier notes linked to the Dow, Nasdaq-100 and Russell 2000 work?
At maturity, if each index is above its initial level, investors receive $1,000 plus 2.0x the gain of the least performing index. If any index is at or below its initial level but all are at or above 70% of initial, investors get back principal only. If any index closes below 70% of its initial value, repayment falls in line with the decline of the least performing index, potentially down to $0.
What are the main risks of the JPMorgan Chase Financial AMJB structured notes?
Key risks include loss of principal if any index finishes below its barrier, no interest or dividend payments, and credit risk to both JPMorgan Financial and JPMorgan Chase & Co. The notes are unsecured, not bank deposits, not FDIC insured, and may be difficult to sell, with secondary market prices likely below the original issue price.
What are the pricing and fees on these JPMorgan Chase Financial barrier notes?
Each note is priced at $1,000 to the public. Selling commissions are $9.50 per $1,000 note, resulting in $990.50 in proceeds to the issuer per note. The initial estimated value is $974.80 per $1,000 note, reflecting selling costs, structuring margin and hedging costs embedded in the issue price.
What indices underlie the AMJB uncapped accelerated barrier notes?
The notes are linked individually to three equity indices: the Dow Jones Industrial Average® (large-cap U.S. blue chips), the Nasdaq-100 Index® (100 large non-financial stocks listed on Nasdaq) and the Russell 2000® Index (small capitalization U.S. stocks). The payout is based on the worst-performing of the three.
Why is the estimated value of the AMJB notes lower than the price to the public?
The estimated value of $974.80 per $1,000 note is calculated using JPMorgan’s internal funding rate and option pricing models. The difference from the issue price reflects selling commissions, projected hedging profits or losses, and hedging costs included in the original price.
How are the AMJB structured notes treated for U.S. federal income tax purposes?
JPMorgan’s special tax counsel believes it is reasonable to treat the notes as open transactions that are not debt instruments for U.S. federal income tax purposes, so gain or loss should generally be capital, and long-term if held for more than one year, though the IRS could challenge this treatment. Investors are also briefed on potential implications of Section 871(m) for non-U.S. holders.